Particularly noteworthy is the strong stromal expression of COL4A1, COL6A3, and COL1A1 in CRC, which multiple studies have associated with adverse clinical outcomes, suggesting their potential utility as stromal-derived prognostic markers [47]. The gene discussed is COL4A1; the disease is colorectal carcinoma.